《梅斯直播课：3天乳腺癌诊疗训练营》2021.7.1问题回答9

2021-07-07 MedSci原创 MedSci原创

《梅斯直播课：3天乳腺癌诊疗训练营》2021.7.1问题回答9

欢迎点赞、评论、分享

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言

评论区 (4)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1277240, encodeId=89f512e724024, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Fri Jul 09 00:14:30 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997046, encodeId=c55f99e0464c, content=很棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c855543406, createdName=ms6000000041276849, createdTime=Wed Jul 07 10:38:39 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997027, encodeId=21ae99e02755, content=很有效, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1465478987, createdName=ms2000000808572741, createdTime=Wed Jul 07 09:56:43 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997019, encodeId=f82599e0194b, content=很好，受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2ef5258527, createdName=147f8cfdm87暂无昵称, createdTime=Wed Jul 07 09:46:41 CST 2021, time=2021-07-07, status=1, ipAttribution=)]
2021-07-09 一闲

#梅斯#

31 0
[GetPortalCommentsPageByObjectIdResponse(id=1277240, encodeId=89f512e724024, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Fri Jul 09 00:14:30 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997046, encodeId=c55f99e0464c, content=很棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c855543406, createdName=ms6000000041276849, createdTime=Wed Jul 07 10:38:39 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997027, encodeId=21ae99e02755, content=很有效, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1465478987, createdName=ms2000000808572741, createdTime=Wed Jul 07 09:56:43 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997019, encodeId=f82599e0194b, content=很好，受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2ef5258527, createdName=147f8cfdm87暂无昵称, createdTime=Wed Jul 07 09:46:41 CST 2021, time=2021-07-07, status=1, ipAttribution=)]
2021-07-07 ms6000000041276849

很棒

69 0
[GetPortalCommentsPageByObjectIdResponse(id=1277240, encodeId=89f512e724024, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Fri Jul 09 00:14:30 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997046, encodeId=c55f99e0464c, content=很棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c855543406, createdName=ms6000000041276849, createdTime=Wed Jul 07 10:38:39 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997027, encodeId=21ae99e02755, content=很有效, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1465478987, createdName=ms2000000808572741, createdTime=Wed Jul 07 09:56:43 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997019, encodeId=f82599e0194b, content=很好，受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2ef5258527, createdName=147f8cfdm87暂无昵称, createdTime=Wed Jul 07 09:46:41 CST 2021, time=2021-07-07, status=1, ipAttribution=)]
2021-07-07 ms2000000808572741

很有效

68 0
[GetPortalCommentsPageByObjectIdResponse(id=1277240, encodeId=89f512e724024, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Fri Jul 09 00:14:30 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997046, encodeId=c55f99e0464c, content=很棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c855543406, createdName=ms6000000041276849, createdTime=Wed Jul 07 10:38:39 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997027, encodeId=21ae99e02755, content=很有效, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1465478987, createdName=ms2000000808572741, createdTime=Wed Jul 07 09:56:43 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997019, encodeId=f82599e0194b, content=很好，受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2ef5258527, createdName=147f8cfdm87暂无昵称, createdTime=Wed Jul 07 09:46:41 CST 2021, time=2021-07-07, status=1, ipAttribution=)]
2021-07-07 147f8cfdm87暂无昵称

很好，受益匪浅

58 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

肿瘤科

《梅斯直播课：3天乳腺癌诊疗训练营》2021.7.1问题回答9

相关资讯

拓展阅读

科室

工具

服务